Episcleral Topotecan for Treatment of Group D Retinoblastoma

Condition:   Retinoblastoma Intervention:   Drug: Episcleral Topotecan Sponsor:   Targeted Therapy Technologies, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials